Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Prostatic Neoplasms 24 Brain Neoplasms 21 Neoplasms 13 Glioma 10 Head and Neck Neoplasms 8 Pancreatic Neoplasms 7 Glioblastoma 6 Lung Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Hepatocellular 5 Astrocytoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Lymphoma 4 Central Nervous System Neoplasms 4 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Spinal Cord Neoplasms 3 Sarcoma 3 Liver Neoplasms 3 Disease 3 Retinoblastoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Oligodendroglioma 2 Neurofibromatosis 1 2 Meningioma 2 Lymphoma, Non-Hodgkin 2

Interventions

Carboplatin 156 Paclitaxel 154 Bevacizumab 96 Cyclophosphamide 61 Gemcitabine 46 olaparib 45 Cisplatin 45 Topotecan 44 niraparib 40 liposomal doxorubicin 40 pembrolizumab 38 Surveys and Questionnaires 33 Filgrastim 31 Hyperthermic Intraperitoneal Chemotherapy 29 Docetaxel 27 Taxes 25 Blood Specimen Collection 24 fludarabine 23 Drug Therapy 23 Cytoreduction Surgical Procedures 23 Peripheral Blood Stem Cell Transplantation 21 Etoposide 21 Doxorubicin 21 Magnetic Resonance Spectroscopy 20 durvalumab 17 Specimen Handling 17 Albumin-Bound Paclitaxel 17 Immunoglobulin G 15 Disulfides 15 Letrozole 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ovarian Neoplasms × Magnetic Resonance Imaging × Clear all

NCT03526809 2018-05-16

MISSION-ovary

Cambridge University Hospitals NHS Foundation Trust

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡